Disease/Infection News

RSS

Effects of implemented vaccine rollout strategies on spread of SARS-CoV-2, subsequent global burden of disease, and emergence of novel variants

Researchers conducted a retrospective analysis to investigate the impact of vaccine-sharing strategies on the heterogenous global distribution of COVID-19 vaccines.

22 Nov 2022

Study shows sylvatic origin of chikungunya virus transmission among nonhuman primates of Myanmar

Researchers investigated the potential exposure of peri-urban non-human primates (NHPs) residing near Yangon to arboviruses that have raised health concerns.

22 Nov 2022

Creating New Targeted Antibacterial Products to Help Tackle Antimicrobial Resistance

We speak to Matthew Dunne, Director for Drug Discovery at Micreos Pharmaceuticals, about the importance of creating new targeted antibacterial products.

22 Nov 2022

Epidemiological and clinical characteristics of monkeypox virus infection in cis and trans women and non-binary individuals

A recent study described the clinical and epidemiologic features of infection with monkeypox virus (MPXV) in cisgender (cis) and transgender (trans) females and non-binary individuals.

22 Nov 2022

Approved and developing passive and active immunizations against respiratory syncytial virus in childhood and pregnancy

Researchers explored active and passive vaccination among children against respiratory syncytial virus (RSV).

22 Nov 2022

US experienced higher COVID-19 mortality during delta and omicron waves

A recent study estimates coronavirus disease 2019-related mortality and excess all-cause mortality in the US and 20 peer countries during the delta and omicron waves of infection.

22 Nov 2022

The biological properties of the SARS-CoV-2 E protein in the context of HIV-1

Researchers assessed the effectiveness of SARS-CoV and SARS-CoV-2 envelope proteins against HIV-1.

22 Nov 2022

Exploring antibiotic resistance in the EU

Antibiotic resistance is one of the greatest threats to global human health and to development.

22 Nov 2022

Potent hypervalent nanoparticles against HIV, Lassa and SARS-CoV-2 variants

In a recent study published in the journal Advanced Science, researchers developed molecularly imprinted nanoparticles (nanoMIPs) with broad-spectrum activity against lethal viruses.

21 Nov 2022

Elevated incidence and risk for a new diagnosis of diabetes after COVID-19

In a recent study published in the journal BMC Medicine, researchers estimated the prevalence of new-onset diabetes following coronavirus disease 2019 (COVID-19).

21 Nov 2022

The WHO announces four MERS cases from Saudi Arabia in recent weeks

A recent disease outbreak alert released by the World Health Organization (WHO) reported four laboratory-confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) from three regions in the Kingdom of Saudi Arabia.

21 Nov 2022

New studies improve understanding of the genetic factors that protect people against COVID-19

Two recent papers by Brazilian researchers have contributed to the scientific understanding of the genetic factors that protect people against infection by SARS-CoV-2 or prevent progression to severe COVID-19.

21 Nov 2022

Study finds no benefits from angiotensin receptor blocker treatment for COVID-19

In a recent study published in the BMJ, researchers conducted a phase three, multicenter, randomized controlled trial to evaluate the effect of using angiotensin receptor blockers that disrupt the renin-angiotensin system on the clinical outcomes of individuals with coronavirus disease 2019 (COVID-19).

21 Nov 2022

Increased distribution of fungal infections throughout the U.S.

Researchers update the geographic distribution of these species throughout the U.S.

21 Nov 2022

Kiwira virus: a new bat-borne hantavirus detected in Africa

Researchers discover a novel hantavirus called the Kiwira virus.

21 Nov 2022

America's health care organizations remind the public about vaccinations and early treatment for COVID-19, influenza

Given the anticipated increase in COVID-19 and influenza cases this fall and winter, America's healthcare professional organizations are coming together to remind the public of the importance of vaccinations and early treatment.

21 Nov 2022

Research links long-term exposure to traffic noise and type 2 diabetes

Road traffic noise is associated with a higher risk of T2D

21 Nov 2022

Additional mRNA COVID vaccine doses could salvage antibody responses in blood cancer patients

A third COVID-19 vaccine dose in this patients with blood cancers could enhance their antibody responses against SARS-CoV-2

21 Nov 2022

NIAID awards more than $12 million for the development of antiviral therapies

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, recently awarded more than $12 million to three institutions for the development of antiviral therapies to treat diseases caused by viruses with pandemic potential.

21 Nov 2022

Johns Hopkins experts receive PCORI funding to optimize antibiotic therapy for gram-negative bloodstream infections

To study how best to treat potentially dangerous infections commonly seen in people with underlying chronic medical conditions, two infectious disease experts at Johns Hopkins Medicine have been awarded $10 million in research funding over five years by the Patient-Centered Outcomes Research Institute.

21 Nov 2022

Disease/Infection News

Effects of implemented vaccine rollout strategies on spread of SARS-CoV-2, subsequent global burden of disease, and emergence of novel variants

Study shows sylvatic origin of chikungunya virus transmission among nonhuman primates of Myanmar

Creating New Targeted Antibacterial Products to Help Tackle Antimicrobial Resistance

Epidemiological and clinical characteristics of monkeypox virus infection in cis and trans women and non-binary individuals

Approved and developing passive and active immunizations against respiratory syncytial virus in childhood and pregnancy

US experienced higher COVID-19 mortality during delta and omicron waves

The biological properties of the SARS-CoV-2 E protein in the context of HIV-1

Exploring antibiotic resistance in the EU

Potent hypervalent nanoparticles against HIV, Lassa and SARS-CoV-2 variants

Elevated incidence and risk for a new diagnosis of diabetes after COVID-19

The WHO announces four MERS cases from Saudi Arabia in recent weeks

New studies improve understanding of the genetic factors that protect people against COVID-19

Study finds no benefits from angiotensin receptor blocker treatment for COVID-19

Increased distribution of fungal infections throughout the U.S.

Kiwira virus: a new bat-borne hantavirus detected in Africa

America's health care organizations remind the public about vaccinations and early treatment for COVID-19, influenza

Research links long-term exposure to traffic noise and type 2 diabetes

Additional mRNA COVID vaccine doses could salvage antibody responses in blood cancer patients

NIAID awards more than $12 million for the development of antiviral therapies

Johns Hopkins experts receive PCORI funding to optimize antibiotic therapy for gram-negative bloodstream infections

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News